 BRISBANE, Calif., Nov. 04, 2020 GLOBE NEWSWIRE -- MyoKardia, Inc. Nasdaq: MYOK today announced three awardees of the 2020 MyoSeedsTM Research Grant Program, who have been selected to receive 250,000 each in support of original, independent research in the biology and underlying mechanisms of cardiomyopathies. The MyoSeeds Program was founded to help advance MyoKardias mission to promote understanding and treatment of the underlying drivers of serious cardiovascular diseases. 